EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India

Debmalya Sanyal, Shinjan Patra, Micol S Rothman

Indian Journal of Endocrinology and Metabolism · 2026-03 · 30 (2) · 164-169

DOI: 10.4103/ijem.ijem_926_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Endocrinology and Metabolism, online erschienen am 30.04.2026. Verfasst von Debmalya Sanyal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, KPC Medical College and Hospital, Kolkata, West Bengal, India. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Testosterone (T) is commonly administered intramuscularly to treat hypogonadal males and female-to-male (FTM) transgender patients. Intramuscular testosterone administration has various drawbacks, including discomfort, bruising, pain, and the need to be administered by a healthcare professional. Self-administered subcutaneous route may be a convenient, safe, and effective alternative. The current study assesses the efficacy and safety of low-dose (50 mg) weekly subcutaneous testosterone administration among FTM transgender.

Methods

The current retrospective cohort study included adult FTM transgender subjects. Participants were administered T-cypionate weekly at a dose of 50 mg and followed up for 6 months. At the end of the follow-up, serum concentrations of testosterone, oestradiol (E2), and the number of participants achieving target E2 (300 ng/mL) in 81% and 68% of subjects, respectively. Ninety-one per cent of subjects had cessation of menstruation. No subject needed to stop testosterone injections or decrease dosage due to polycythaemia (PCV > 50%).

Conclusion

Weekly self-administered 50 mg low-dose, subcutaneous testosterone injection was effective in achieving target testosterone and oestradiol levels in FTM transgender subjects, without significant safety issues.

Schlagwörter

Stichwörter der Autor:innen

Intramuscular testosteronepolycythaemiaself-administrationsubcutaneous testosteronetransgender men

Autor:innen und Institutionen

  • Department of Endocrinology, KPC Medical College and Hospital, Kolkata, West Bengal, India.
  • Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
  • Department of Medicine, Endocrinology, Diabetes and Metabolism, University of Colorado School of Medicine, Aurora, CO, United States of America.

Zitieren

APA

Sanyal, D., Patra, S., & Rothman, M. S. (2026). Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India. Indian Journal of Endocrinology and Metabolism, 30(2), 164-169. https://doi.org/10.4103/ijem.ijem_926_25

Vancouver

Sanyal D, Patra S, Rothman MS. Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India. Indian Journal of Endocrinology and Metabolism. 2026;30(2):164-169. doi:10.4103/ijem.ijem_926_25

BibTeX
@article{Sanyal2026,
  author = {Sanyal, Debmalya and Patra, Shinjan and Rothman, Micol S},
  title = {Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India},
  journal = {Indian Journal of Endocrinology and Metabolism},
  year = {2026},
  volume = {30},
  number = {2},
  pages = {164--169},
  doi = {10.4103/ijem.ijem_926_25}
}
Kostenlos starten →